Gao H - Search Results

1

Prognostic Value of a Category Based on Electron Microscopic Features of Clival Chordomas.

Bai J, Zhai Y, Wang S, Gao H, Du J, Wang J, Li M, Li C, Gui S, Zhang C, Sun Y, Zhang Y. Bai J, et al. Among authors: gao h. World Neurosurg. 2017 Mar;99:282-287. doi: 10.1016/j.wneu.2016.11.117. Epub 2016 Dec 1. World Neurosurg. 2017. PMID: 27916725

2

Overexpression of the Notch3 receptor and its ligand Jagged1 in human clinically non-functioning pituitary adenomas.

Lu R, Gao H, Wang H, Cao L, Bai J, Zhang Y. Lu R, et al. Among authors: gao h. Oncol Lett. 2013 Mar;5(3):845-851. doi: 10.3892/ol.2013.1113. Epub 2013 Jan 7. Oncol Lett. 2013. PMID: 23426998 Free PMC article.

3

Reversal of multidrug resistance by magnetic chitosan-Fe₃O₄ nanoparticle-encapsulated MDR₁ siRNA in glioblastoma cell line.

Zhao P, Wang H, Gao H, Li C, Zhang Y. Zhao P, et al. Among authors: gao h. Neurol Res. 2013 Oct;35(8):821-8. doi: 10.1179/1743132813Y.0000000218. Epub 2013 May 3. Neurol Res. 2013. PMID: 23651652

4

Low levels of PRB3 mRNA are associated with dopamine-agonist resistance and tumor recurrence in prolactinomas.

Wang F, Gao H, Li C, Bai J, Lu R, Cao L, Wu Y, Hong L, Wu Y, Lan X, Zhang Y. Wang F, et al. Among authors: gao h. J Neurooncol. 2014 Jan;116(1):83-8. doi: 10.1007/s11060-013-1276-2. Epub 2013 Oct 18. J Neurooncol. 2014. PMID: 24135847

5

Effects of the estrogen receptor antagonist fulvestrant on F344 rat prolactinoma models.

Cao L, Gao H, Gui S, Bai G, Lu R, Wang F, Zhang Y. Cao L, et al. Among authors: gao h. J Neurooncol. 2014 Feb;116(3):523-31. doi: 10.1007/s11060-013-1351-8. Epub 2014 Jan 10. J Neurooncol. 2014. PMID: 24407733

6

The Wnt/β-catenin signaling pathway is involved in the antitumor effect of fulvestrant on rat prolactinoma MMQ cells.

Cao L, Gao H, Li P, Gui S, Zhang Y. Cao L, et al. Among authors: gao h. Tumour Biol. 2014 Jun;35(6):5121-7. doi: 10.1007/s13277-013-1571-8. Epub 2014 Mar 19. Tumour Biol. 2014. PMID: 24643679

7

Lower PRDM2 expression is associated with dopamine-agonist resistance and tumor recurrence in prolactinomas.

Gao H, Wang F, Lan X, Li C, Feng J, Bai J, Cao L, Gui S, Hong L, Zhang Y. Gao H, et al. BMC Cancer. 2015 Apr 12;15:272. doi: 10.1186/s12885-015-1267-0. BMC Cancer. 2015. PMID: 25884948 Free PMC article.

8

The role of FSCN1 in migration and invasion of pituitary adenomas.

Liu C, Gao H, Cao L, Gui S, Liu Q, Li C, Li D, Gong L, Zhang Y. Liu C, et al. Among authors: gao h. Mol Cell Endocrinol. 2016 Jan 5;419:217-24. doi: 10.1016/j.mce.2015.10.021. Epub 2015 Oct 29. Mol Cell Endocrinol. 2016. PMID: 26522130

9

Assessment of sFRP4 as a bio-marker for predicting aggressiveness and recurrence of growth hormone-secreting pituitary adenomas.

Wu Y, Liu C, Yu S, Gao H, Li Z, Li C, Zhang Y. Wu Y, et al. Among authors: gao h. Oncol Rep. 2016 May;35(5):2991-9. doi: 10.3892/or.2016.4650. Epub 2016 Mar 3. Oncol Rep. 2016. PMID: 26935389

10

Use of micro-positron emission tomography with (18)F-fallypride to measure the levels of dopamine receptor-D2 and (18)F-FDG as molecular imaging tracer in the pituitary glands and prolactinomas of Fischer-344 rats.

Li P, Gui S, Cao L, Gao H, Bai J, Li C, Zhang Y. Li P, et al. Among authors: gao h. Onco Targets Ther. 2016 Apr 6;9:2057-68. doi: 10.2147/OTT.S94057. eCollection 2016. Onco Targets Ther. 2016. PMID: 27103832 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

17,152 results

Search Page

Filters